Predictive risk scale for developing a large fetus

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

BACKGROUND: There is a need to search for early prognostic markers of macrosomia development due to the increase in the incidence of fetal macrosomia, the high risk of maternal and neonatal complications, and the lack of an algorithm for prenatal monitoring. It can improve the accuracy of diagnosis, optimize obstetric management of pregnancy and childbirth, and prevent fetal macrosomia.

AIM: The aim of this study was to develop a scale for predicting macrosomia based on the study of the prognostic value of its risk factors and antifactors.

MATERIALS AND METHODS: The authors conducted a single-center prospective cohort study at the Orenburg Clinical Perinatal Center, Orenburg, Russia, and studied 676 pregnant women with large fetuses (main group) and 600 pregnant women with medium-weight fetuses (control group), as well as their newborns. The observation and study was performed from January 1, 2015 to January 1, 2020.

RESULTS: The large size of the fetus in women without pre-existing and manifest forms of diabetes mellitus is determined to varying degrees by both non-modifiable risk factors and modifiable ones, including obesity, pathological weight gain during pregnancy, especially in the third trimester, excessive consumption of carbohydrates, and low physical activity.

CONCLUSIONS: Calculation of the integrated influence of various factors on the development of a large fetus revealed a number of factors and antifactors in predicting fetal macrosomia. In practical obstetrics, it is advisable to use formalized tables of risk factors for the development of a large fetus, according to the identified prognostic coefficients.

全文:

受限制的访问

作者简介

Irina Baeva

Orenburg State Medical University

Email: baeva37@mail.ru
ORCID iD: 0009-0000-4447-6762
SPIN 代码: 5416-2362

MD, Cand. Sci. (Med.)

俄罗斯联邦, Orenburg

Olga Konstantinova

Orenburg State Medical University

编辑信件的主要联系方式.
Email: const55@mail.ru
ORCID iD: 0000-0003-0369-0281
SPIN 代码: 2067-5253

MD, Dr. Sci. (Med.), Professor

俄罗斯联邦, Orenburg

参考

  1. Odinokova VA, Shmakov RG, Chagovets VV. Prediction, prevention and management of pregnancy and delivery in fetal macrosomia. Obstetrics and Gynecology. 2018;(1):14–20. (In Russ.) doi: 10.18565/aig.2018.1.14-20
  2. Gevorkyan RS. Makrosomiya ploda: kliniko-biokhimicheskie determinanty. Osobennosti techeniya beremennosti, rodov, perinatal’nye iskhody [abstract dissertation]. Chelyabinsk; 2017 [cited 2023 Aug 12]. Available from: https://www.dissercat.com/content/makrosomiya-ploda-kliniko-biokhimicheskie-determinanty-osobennosti-techeniya-beremennosti. (In Russ.)
  3. Usta A, Usta CS, Yildiz A, et al. Frequency of fetal macrosomia and the associated risk factors in pregnancies without gestational diabetes mellitus. Pan Afr Med J. 2017;26:62. doi: 10.11604/pamj.2017.26.62.11440
  4. Wang D, Hong Y, Zhu L, et al. Risk factors and outcomes of macrosomia in China: a multicentric survey based on birth data. J Matern Fetal Neonatal Med. 2017;30(5):623–627. doi: 10.1080/14767058.2016.1252746
  5. Beta J, Khan N, Khalil A, et al. Maternal and neonatal complications of fetal macrosomia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;54(3):308–318. doi: 10.1002/uog.20279
  6. Scifres CM. Short- and long-term outcomes associated with large for gestational age birth weight. Obstet Gynecol Clin North Am. 2021;48(2):325–337. doi: 10.1016/j.ogc.2021.02.005
  7. Tagunets NI. Prognozirovanie i diagnostika makrosomii ploda u beremennykh gruppy riska [abstract dissertation]. Kazan’, 2014. (In Russ.) Available from: https://www.dissercat.com/content/prognozirovanie-i-diagnostika-makrosomii-ploda-u-beremennykh-gruppy-riska
  8. Cherepnina AL, Panina OB, Oleshkevich LN. Management of pregnancy and labor with large fetus. Voprosy ginekologii, akusherstva i perinatologii. Gynecology, Obstetrics and Perinatology. 2005;(1):15–19. (In Russ.)
  9. Salihu HM, Dongarwar D, King LM, et al. Phenotypes of fetal macrosomia and risk of stillbirth among term deliveries over the previous four decades. Birth. 2020;47(2):202–210. doi: 10.1111/birt.12479
  10. Nguyen MT, Ouzounian JG. Evaluation and management of fetal macrosomia. Obstet Gynecol Clin North Am. 2021;48(2):387–399. doi: 10.1016/j.ogc.2021.02.008
  11. Wang C, Wei Y, Zhang X, et al. A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women. Am J Obstet Gynecol. 2017;216(4):340–351. doi: 10.1016/j.ajog.2017.01.037
  12. Barakat R, Pelaez M, Cordero Y, et al. Exercise during pregnancy protects against hypertension and macrosomia: randomized clinical trial. Am J Obstet Gynecol. 2016;214(5):649.e1–649.e6498. doi: 10.1016/j.ajog.2015.11.039
  13. Santos S, Voerman E, Amiano P, et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European. North American and Australian cohorts. BJOG. 2019;126(8):984–995. doi: 10.1111/1471-0528.15661
  14. Zbucka-Kretowska M, Kuzmicki M, Telejko B, et al. First-trimester irisin and fetuin-A concentration in predicting macrosomia. J Matern Fetal Neonatal Med. 2019;32(17):2868–2873. doi: 10.1080/14767058.2018.1450859

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eсо-Vector, 2023

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



##common.cookie##